CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 26,489 | ||
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion | +2,813 | $16.14 | $45K | 3,912 |
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion | +1,530 | $2.21 | $3K | 4,722 |
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion | +157 | $0.28 | $44 | 4,879 |
| 2022-03-28 | Carey John F VP of Operations | Sale | −4,500 | $25.01 | $113K | 379 |
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −2,813 | 8,125 | ||
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,530 | 10,743 | ||
| 2022-03-28 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −157 | 27,989 | ||
| 2022-02-22 | Carey John F VP of Operations | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2022-02-22 | Khayal Tamer I Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2022-02-22 | DAMME LAURA VP, Clinical Affairs | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2022-02-22 | Provost Miriam VP of Global Regl. Affairs | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2022-02-22 | Hassanein Waleed H President & CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-02-22 | Gordon Stephen Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2022-01-06 | Hassanein Waleed H President & CEO | Exercise or conversion | +122,371 | $0.28 | $34K | 526,214 |
| 2022-01-06 | Hassanein Waleed H President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −122,371 | 0 | ||
| 2021-12-23 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion | +884 | $3.22 | $3K | 9,438 |
| 2021-12-23 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion · Stock Option (Right to Buy) | −884 | 20,881 | ||
| 2021-12-15 | TOBIN JAMES R Director | Gift | −25,500 | 399,137 | ||
| 2021-11-29 | KANIA EDWIN M JR Director | Purchase | +25,938 | $22.14 | $574K | 228,831 |
Page 40 of 49 · 980 trades